# Selera Medical

> Selera Medical is a Y Combinator-backed (W24) medical device startup building MILO - minimally invasive lymphatic offloading - a one-time, catheter-based procedure that treats fluid overload in chronic heart failure. Instead of a lifelong drug regimen, Selera taps the body's lymphatic system to drain trapped fluid from the interstitial space, aiming to break the cycle of repeat hospitalizations that defines late-stage heart failure. Founded in 2023 by CEO Stacie Arechavala and CTO Kevin Bui, both former Stanford Biodesign fellows.

- **Founded:** 2023
- **Headquarters:** Mountain View, California, United States
- **Founders:** Stacie Arechavala (Cofounder & CEO), Kevin Bui (Cofounder & CTO)
- **Team size:** 2-3
- **Products:** MILO (Minimally Invasive Lymphatic Offloading)
- **Notable:** Accepted into Y Combinator's Winter 2024 (W24) batch, Raised a $500K pre-seed round (April 2024), Founded by two former Stanford Biodesign Innovation Fellows

## Products & services

- **MILO (Minimally Invasive Lymphatic Offloading)** — A one-time, minimally invasive procedure that leverages the body's lymphatic system to drain trapped interstitial fluid, addressing the fluid overload that drives most heart failure symptoms and hospitalizations. Positioned as a long-term treatment that avoids a lifelong drug regimen.

## Achievements

- Accepted into Y Combinator's Winter 2024 (W24) batch
- Raised a $500K pre-seed round (April 2024)
- Founded by two former Stanford Biodesign Innovation Fellows
- Developed MILO, a novel lymphatic-offloading approach to heart failure fluid overload

## Latest updates

- **2024-03** — Launched publicly out of Y Combinator's W24 batch with the MILO lymphatic-offloading approach to heart failure.
- **2024-04** — Closed a $500K pre-seed round.

## Links

- Website: https://seleramedical.com
- LinkedIn: https://www.linkedin.com/company/selera-medical

---

Profile page: https://yespress.io/selera-medical-yc-w24
Published by YesPress — https://yespress.io
Last updated: 2026-07-30